LTM LIMITED vs SYNOPTICS TECHNOLOGIES L

A side-by-side comparison of LTM LIMITED (LTM) and SYNOPTICS TECHNOLOGIES L (SYNOPTICS) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, LTM LIMITED leads LTM vs SYNOPTICS on 12 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability40
  • Growth20
  • Size & financial health40
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

27.30
P/E ratio
10.80
4.54
P/B ratio
0.66
1.68%
Dividend yield
0.00%
₹169.25
EPS
₹4.82

Profitability

LTM takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

23.10%
Return on equity
5.70%
30.00%
Return on capital
7.22%
18.00%
EBITDA margin
17.62%
11.78%
Net margin
7.17%

Growth

LTM takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

8.43%
Revenue CAGR (3Y)
3.81%
4.16%
Profit CAGR (3Y)
-14.87%

Size & financial health

LTM takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.37L Cr
Market cap
₹49 Cr
₹42,308 Cr
Revenue
₹57 Cr
₹4,983 Cr
Net profit
₹4 Cr
0.09
Debt / equity
0.45
LTM LIMITED
  • + ["Company has a good return on equity (ROE) track record: 3 Years ROE 23.1%", "Company has been maintaining a healthy dividend payout of 42.7%", "Company's working capital requirements have reduced from 33.8 days to 26.4 days"]
SYNOPTICS TECHNOLOGIES L
  • + ["Stock is trading at 0.66 times its book value"]
  • ["Though the company is reporting repeated profits, it is not paying out dividend", "The company has delivered a poor sales growth of 10.5% over past five years.", "Company has a low return on equity of 7.64% over last 3 years.", "Company might be capitalizing the interest cost"]
LTM LIMITED full analysis SYNOPTICS TECHNOLOGIES L full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.